Back
Aligos Therapeutics Stock Price Chart
The #1 Energy Passive Income Investment for 2023The #1 Energy Passive Income Investment for 2024
CLICK HERE TO FIND OUT WHAT IT IS.
Buy
74
ALGS
Aligos Therapeutics
Last Price:
31.57
Seasonality Move:
10.65%
7 Day Trial
ALL ACCESS PASS
$
7
A 10,000% Dividend?!?
Watch the short presentation by clicking here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 22.81 | Buy |
| 50-day SMA: | 14.24 | Buy |
| 200-day SMA: | 15.81 | Buy |
| 8-day EMA: | 27.13 | Buy |
| 20-day EMA: | 22.88 | Buy |
| 50-day EMA: | 17.49 | Buy |
| 200-day EMA: | 15.94 | Buy |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.32 | Buy |
| Relative Strength Index (14 RSI): | 81.62 | Buy |
| Chaikin Money Flow: | 315379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.3 - 26.46) | Buy |
| Bollinger Bands (100): | (7.85 - 19.03) | Buy |
Aligos Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 30.82 while ALGS 8-day simple moving average is 27.35, which is a Buy signal.
- The stock price of ALGS is 30.82 while Aligos Therapeutics 20-day SMA is 22.81, which makes it a Buy.
- Aligos Therapeutics 50-day simple moving average is 14.24 while ALGS share price is 30.82, making it a Buy technically.
- ALGS stock price is 30.82 and Aligos Therapeutics 200-day simple moving average is 15.81, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Buy
The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
110.58M
Price in USD:
30.82
Share Volume:
540.98K
Aligos Therapeutics 52-Week Range
52-Week High:
31.80
52-Week Low:
6.76
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?
The Aligos Therapeutics stock price is 30.82 USD today. -
Will ALGS stock go up or go down?
Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aligos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is not overvalued.
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 30.82 while ALGS 8-day exponential moving average is 27.13, which is a Buy signal.
- The stock price of ALGS is 30.82 while Aligos Therapeutics 20-day EMA is 22.88, which makes it a Buy.
- Aligos Therapeutics 50-day exponential moving average is 17.49 while ALGS share price is 30.82, making it a Buy technically.
- ALGS stock price is 30.82 and Aligos Therapeutics 200-day simple moving average is 15.94, creating a Buy signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
- ALGS Moving Average Covergence Divergence (MACD) indicator is 4.32, suggesting Aligos Therapeutics is a Buy
- Aligos Therapeutics Relative Strength Index (RSI) is 81.62, which suggest Aligos Therapeutics is overbought
- The Bollinger Bands (25) for Aligos Therapeutics is (14.3 - 26.46), which suggest Aligos Therapeutics is a Buy
- The Bollinger Bands (100) for Aligos Therapeutics is (7.85 - 19.03), which suggest Aligos Therapeutics is a Buy
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.